BioSpace News Archive

Puma Biotechnology, Inc., a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2020.

TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced its operating and financial results for the third quarter of 2020.

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring systems for people with diabetes, announced the company plans to participate in the upcoming Credit Suisse virtual Healthcare Conference.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced financial results for the third quarter ended September 30, 2020.

Maxar Technologies, a trusted partner and innovator in Earth Intelligence and Space Infrastructure, announced financial results for the quarter ended September 30, 2020.

Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced financial results for the third quarter ended September 30, 2020 and provided corporate updates.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today reported recent business highlights, anticipated upcoming milestones, and financial results for the third quarter and first nine months of 2020.

Shovels hit the dirt yesterday as Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters on 1180 East Ellsworth Road in Ann Arbor, MI.

Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the third quarter of 2020.

IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its third quarter 2020 financial results after market close on Thursday, November 12, 2020.